These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 8797862)
21. Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression. Barbareschi M; Pelosio P; Caffo O; Buttitta F; Pellegrini S; Barbazza R; Dalla Palma P; Bevilacqua G; Marchetti A Int J Cancer; 1997 Apr; 74(2):171-4. PubMed ID: 9133450 [TBL] [Abstract][Full Text] [Related]
22. Frequent amplification of the cyclin E gene in human gastric carcinomas. Akama Y; Yasui W; Yokozaki H; Kuniyasu H; Kitahara K; Ishikawa T; Tahara E Jpn J Cancer Res; 1995 Jul; 86(7):617-21. PubMed ID: 7559076 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550 [TBL] [Abstract][Full Text] [Related]
24. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112 [TBL] [Abstract][Full Text] [Related]
25. Amplification of cyclin genes in colorectal carcinomas. Leach FS; Elledge SJ; Sherr CJ; Willson JK; Markowitz S; Kinzler KW; Vogelstein B Cancer Res; 1993 May; 53(9):1986-9. PubMed ID: 8481900 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma. Frierson HF; Gaffey MJ; Zukerberg LR; Arnold A; Williams ME Mod Pathol; 1996 Jul; 9(7):725-30. PubMed ID: 8832554 [TBL] [Abstract][Full Text] [Related]
27. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma. Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224 [TBL] [Abstract][Full Text] [Related]
28. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters. Naidu R; Wahab NA; Yadav MM; Kutty MK Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618 [TBL] [Abstract][Full Text] [Related]
30. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551 [TBL] [Abstract][Full Text] [Related]
31. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583 [TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast. Vos CB; Ter Haar NT; Peterse JL; Cornelisse CJ; van de Vijver MJ J Pathol; 1999 Feb; 187(3):279-84. PubMed ID: 10398079 [TBL] [Abstract][Full Text] [Related]
33. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status. Jares P; Rey MJ; Fernández PL; Campo E; Nadal A; Muñoz M; Mallofré C; Muntané J; Nayach I; Estapé J; Cardesa A J Pathol; 1997 Jun; 182(2):160-6. PubMed ID: 9274525 [TBL] [Abstract][Full Text] [Related]
34. Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. Pelosio P; Barbareschi M; Bonoldi E; Marchetti A; Verderio P; Caffo O; Bevilacqua P; Boracchi P; Buttitta F; Barbazza R; Dalla Palma P; Gasparini G Ann Oncol; 1996 Sep; 7(7):695-703. PubMed ID: 8905027 [TBL] [Abstract][Full Text] [Related]
35. Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas. Masciullo V; Scambia G; Marone M; Giannitelli C; Ferrandina G; Bellacosa A; Benedetti Panici P; Mancuso S Int J Cancer; 1997 Aug; 74(4):390-5. PubMed ID: 9291427 [TBL] [Abstract][Full Text] [Related]
36. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Naitoh H; Shibata J; Kawaguchi A; Kodama M; Hattori T Am J Pathol; 1995 May; 146(5):1161-9. PubMed ID: 7747810 [TBL] [Abstract][Full Text] [Related]
37. INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. Hui R; Macmillan RD; Kenny FS; Musgrove EA; Blamey RW; Nicholson RI; Robertson JF; Sutherland RL Clin Cancer Res; 2000 Jul; 6(7):2777-87. PubMed ID: 10914724 [TBL] [Abstract][Full Text] [Related]
38. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line. Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766 [TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma. Davidson BJ; Lydiatt WM; Abate MP; Schantz SP; Chaganti RS Head Neck; 1996; 18(6):512-21. PubMed ID: 8902564 [TBL] [Abstract][Full Text] [Related]
40. Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Kurzrock R; Ku S; Talpaz M Cancer; 1995 Jan; 75(2):584-90. PubMed ID: 7812927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]